Suppr超能文献

阿莫西林+克拉维酸与氨苄西林+舒巴坦联合用药对50株产β-内酰胺酶流感嗜血杆菌的体外活性比较

[Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].

作者信息

Moittie D, Simonet M, Veron M

机构信息

Laboratoire de Microbiologie, Hôpital Necker-Enfants Malades, Paris.

出版信息

Pathol Biol (Paris). 1989 May;37(5):390-3.

PMID:2789362
Abstract

We compared the ability of two beta lactamase inhibitors, clavulanic acid and sulbactam, to reduce the minimal inhibitory concentrations (MICs) respectively of amoxycillin and ampicillin against fifty strains of Haemophilus influenzae producing a beta lactamase. The reduction of MICs of aminopenicillins was studied using low concentrations of beta lactamase inhibitors (0.125 to 0.5 mg/l). Moreover, the synergic effect of each association was evaluated against a heavy bacterial inoculum (10(8) cfu/ml). The combination of amoxycillin + clavulanic acid was more synergic on these strains than the association of ampicillin + sulbactam.

摘要

我们比较了两种β-内酰胺酶抑制剂——克拉维酸和舒巴坦,分别降低阿莫西林和氨苄西林对50株产β-内酰胺酶的流感嗜血杆菌的最低抑菌浓度(MICs)的能力。使用低浓度的β-内酰胺酶抑制剂(0.125至0.5mg/l)研究氨基青霉素MICs的降低情况。此外,还评估了每种联合用药对高浓度细菌接种物(10⁸cfu/ml)的协同作用。在这些菌株上,阿莫西林+克拉维酸的联合用药比氨苄西林+舒巴坦的联合用药具有更强的协同作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验